Mergers and Acquisitions

Gilead to buy Kite Pharma for roughly $11B in cash

Gilead Sciences has agreed to pay about $11 billion for Kite Pharma and its promising new technology for harnessing the body's immune system to fight cancer, according to people familiar with the matter.

China merging state-owned energy giants

China's government says it will merge two of its biggest coal and power companies amid a campaign to make state industry that dominates the economy more efficient and profitable.

EU probes Bayer's planned buyout of Monsanto

The European Union's anti-trust watchdog has launched a probe into German chemical maker Bayer's planned buyout of U.S. seed and weed-killer company Monsanto.

EU probes Bayer's planned buyout of Monsanto

The European Union's anti-trust watchdog has launched a probe into German chemical maker Bayer's planned buyout of U.S. seed and weed-killer company Monsanto.